MODALTIN
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Feb 2026)
What this means for you
This application is over — abandoned 02 Feb 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97424052
- Mark type
- Stylized text
- Filed
- 23 May 2022
- Published for opposition
- 01 Nov 2022
- Abandoned
- 02 Feb 2026
- Attorney of record
- Francis J. Duffin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders
Owner
- TONIX PHARMACEUTICALS, INC., Chatham, NJ, US
- TONIX PHARMACEUTICALS, INC., New York, NY, US
Prosecution history
- 02 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2025 — SOU EXTENSION 5 GRANTED
- 23 Jun 2025 — SOU EXTENSION 5 FILED
- 10 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2024 — SOU EXTENSION 4 GRANTED
- 12 Dec 2024 — SOU EXTENSION 4 FILED
- 12 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2024 — SOU EXTENSION 3 GRANTED